Tag: inflammation

Following the successful conclusion of the ENDO 2026 annual meeting in Chicago, the Endocrine Society has announced a robust schedule of specialized programming for the fall season, targeting both fundamental research and clinical application. The upcoming calendar represents a strategic pivot from large-scale general assemblies toward focused, high-intensity symposia designed to address specific gaps in…

The field of endocrinology is currently undergoing a transformative period, marked by a shift from purely academic research toward a more integrated, patient-centered approach that emphasizes leadership, advocacy, and metabolic holism. Recent developments across various sub-specialties—ranging from reproductive health and oncology to metabolic pharmacology—illustrate a growing recognition of the complex interplay between hormonal systems and…

The landscape of American biomedical research faces a period of significant transition and potential volatility as the Office of Management and Budget (OMB) moves forward with a series of proposed regulatory changes that could redefine the relationship between federal agencies and the scientific community. On May 29, the OMB unveiled a set of sweeping revisions…

The upcoming ENDO 2026 meeting is set to showcase a rare intersection of familial legacy and scientific synergy as two generations of the Dumesic family present distinct but deeply interconnected research programs. Dr. Daniel Dumesic, a renowned expert in reproductive endocrinology at the David Geffen School of Medicine at UCLA, and his son, Dr. Phillip…

The medical community has long operated under the assumption that significant weight loss naturally catalyzes an increase in physical activity as the biological and mechanical burdens of obesity are lifted. However, a groundbreaking retrospective cohort study presented at the ENDO 2024 annual meeting in Boston suggests that the reality for patients utilizing GLP-1 receptor agonists…

The American Medical Association (AMA) House of Delegates convened in Chicago this past June to deliberate on and establish pivotal policy positions that will guide the future of healthcare delivery, patient advocacy, and physician standards across the United States. Representing the specialized interests of the endocrine community, the Endocrine Society dispatched a distinguished delegation comprising…

The Endocrine Society has officially named Katrin Svensson, PhD, as the recipient of the 2026 Richard E. Weitzman Outstanding Early Career Investigator Award, a distinction that highlights her significant contributions to the understanding of intercellular communication and metabolic regulation. As an associate professor in the Department of Pathology at Stanford University and the Metabolic Core…

The Intersection of Hypercortisolism and Metabolic Dysfunction Endogenous Cushing’s syndrome is a rare but debilitating endocrine disorder characterized by the chronic overproduction of cortisol by the adrenal glands. This hypercortisolism can stem from various sources, most commonly a pituitary tumor (Cushing’s disease), an adrenal tumor, or, more rarely, ectopic ACTH-secreting tumors. Cortisol is often referred…

The annual ENDO meeting, hosted by the Endocrine Society, stands as the premier global gathering for clinicians, researchers, and educators in the field of endocrinology. With the conclusion of the most recent sessions and the approach of ENDO 2026 in Chicago, the international medical community has paused to reflect on the profound influence this conference…

The administration of denosumab, a high-potency monoclonal antibody used to manage bone complications in cancer patients, has been linked to a rare and life-threatening metabolic crisis characterized by profound mineral depletion. A landmark case study published in JCEM Case Reports details a "hungry bone syndrome-like state" occurring in a 76-year-old male with multiple myeloma, a…